BR100 Decreased By (-0.03%)
BR30 Decreased By (-0.19%)
KSE100 Decreased By (-0.25%)
KSE30 Decreased By (-0.48%)
BECO 5.86 Decreased By ▼ -0.17 (-2.82%)
BML 57.79 Increased By ▲ 5.04 (9.55%)
BOP 33.84 Decreased By ▼ -0.41 (-1.2%)
CNERGY 8.16 No Change ▼ 0.00 (0%)
DCL 11.78 Decreased By ▼ -0.56 (-4.54%)
FCCL 53.68 Decreased By ▼ -0.21 (-0.39%)
FCSC 5.47 Increased By ▲ 0.25 (4.79%)
FFL 17.83 Decreased By ▼ -0.20 (-1.11%)
FNEL 1.30 No Change ▼ 0.00 (0%)
HUMNL 11.15 Increased By ▲ 0.15 (1.36%)
KEL 8.09 Decreased By ▼ -0.02 (-0.25%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 88.17 Increased By ▲ 0.12 (0.14%)
NBP 183.60 Decreased By ▼ -2.88 (-1.54%)
PACE 11.66 Increased By ▲ 0.94 (8.77%)
PAEL 40.25 Increased By ▲ 0.31 (0.78%)
PIAHCLA 26.16 Decreased By ▼ -0.01 (-0.04%)
PIBTL 17.24 Decreased By ▼ -0.08 (-0.46%)
PPL 230.88 Decreased By ▼ -1.90 (-0.82%)
PRL 34.49 Decreased By ▼ -0.46 (-1.32%)
PTC 67.70 Increased By ▲ 0.14 (0.21%)
SEARL 91.33 Increased By ▲ 0.40 (0.44%)
SSGC 26.89 Decreased By ▼ -0.28 (-1.03%)
TELE 8.57 No Change ▼ 0.00 (0%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.42 Increased By ▲ 0.66 (7.53%)
TREET 24.57 Increased By ▲ 0.03 (0.12%)
TRG 71.99 Increased By ▲ 0.24 (0.33%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
By

The World Health Organization on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.

The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.

AstraZeneca bolsters COVID therapeutics with RQ Bio deal

The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe COVID-19, the agency said.

Other vaccines that have similar clearance from the agency include those made by Pfizer Inc and BioNTech, Moderna Inc, AstraZeneca Plc, Johnson & Johnson and Novavax Inc.

Comments

Comments are closed for this article.